Suchergebnisse - "Rimassa, Lorenza"

PubPharm (11)

1

Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab

enthalten in: Targeted oncology | 2024

von Rimini, M. | Loi, E. | Rizzato, M. | +26

2

Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab

enthalten in: Targeted oncology | 2024

von Rimini, M. | Loi, E. | Rizzato, M. | +26

3

Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma : How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?

enthalten in: Targeted oncology | 2023

von Rimini, M. | Persano, M. | Tada, T. | +67

4

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas : An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

5

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

6

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

7

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

8

Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer : Real-World Data from the RAMoss Study

enthalten in: Targeted oncology | 2018

von Di Bartolomeo, M. | Niger, M. | Tirino, G. | +28

9

Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study

enthalten in: Targeted oncology | 2018

von Di Bartolomeo, M. | Niger, M. | Tirino, G. | +28

10

Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study

enthalten in: Targeted oncology | 2018

von Di Bartolomeo, M. | Niger, M. | Tirino, G. | +28